- Screening
- Baseline
- In the process of the treatment
- At the end of the treatment
- Follow-up 1
- Follow-up 2
- Follow-up 3
- Management system of participants
- Speciman management system
- Data management system
- ADR/ADE management system
- Madicine management system
- Instruments management system
- SOPs
- Research team
- Design, Methods
|
Eligible participant has to fullfill all of the following items | / / / / / / |
|
|
|
Date | yyyy-mm-dd |
- General information
- Physical examination
- Blood Routine Tests
- Urine and Stool Routine Tests
- Glucose test
- Serum Liver Function Tests
- Renel Function Test
- Heat Function Examination
- Image Examinations
|
Gender | Male
|
|
Your age | 45 岁(years) |
|
Date of birth: | 1974 yyyy-mm-dd |
|
Nationality | Han
|
|
Marriage history | |
|
Pulse rate | 78 次/分 |
|
Breath frequency | 20 次/分 |
|
Systolic pressure (SP) | 130 mmHg |
|
Diastolic pressure | 90 mmHg |
|
Did you experienced any drug allergy? | No
|
|
Namy of the drug to be allergied |
|
|
Date of drug allergy happened | yyyy-mm-dd/mm-dd |
|
Doctor signature | liufeng |
|
Date | 2019-11-07 yyyy-mm-dd |
0 |
|
|
Wagner grade | |
|
Signature of the doctor | liuf |
|
Date of examination | 2019-11-07 yyyy-mm-dd |
|
WBC | 4.2 ×109 /L |
|
NEUT% | 60 % |
|
LY% | 35 % |
|
MONO％ | 30 ％ |
|
RBC | 5.5 ×10^12 /L |
|
HGB | 90 g/L |
|
PLT | 200 ×10^9 /L |
|
Date | 2019-11-07 yyyy-mm-dd |
|
Acidity and allkalinity | alkalinity
|
|
pH value | 7.44 |
|
Urine protein | Positive++
|
|
Urine red cell | Positive+
|
|
Urine WBC | Positive++
|
|
Urine glucos | Positive++++
|
|
Urine Bilirubin | Positive++
|
|
Urine HCG | Negative
|
|
KET | Positive++
|
|
SG |
|
|
UBG | Positive+
|
|
NIT | Positive++
|
|
Date of test | yyyy-mm-dd |
|
Fasting blood glucos concentration | 9.9 mmol/L |
|
Two hours after breakfast | 16 mmol/L |
|
Two hours after lunch | 14 mmol/L |
|
Two hours after dinner | 18 mmol/L |
|
Date of test | 2019-11-07 yyyy-mm-dd |
|
CRP | 80 mg/L |
|
Date of test | 2019-11-07 yyyy-mm-dd |
|
Fib | g/L |
|
t-PA | ug/L |
|
PAI-1 | ug/L |
|
Date of test |
|
|
HbA1c | 8 % |
|
Date of test | yyyy-mm-dd |
|
ALT | IU/L |
|
AST | IU/L |
|
γ-Glutamyltransferase | IU/L |
|
Serum bilirubin | μmol/L |
|
Indirect bilirubin | umol/L |
|
Direct bilirubin | umol/L |
|
Serum albumin | g/L |
|
Serum total protein | g/L |
|
Date of test | yyyy-mm-dd |
|
Blood uric acid | μmol/L |
|
SCr | μmol/L |
|
Blood urea | mmol/L |
|
Date of test | yyyy-mm-dd |
|
Ultrasonic echocardiography, UCG | |
|
Description in detail for abnormal |
|
|
Date of examination | yyyy-mm-dd |
|
AST | U |
|
LDH | IU |
|
Lactic dehydrogenase isoenzyme | |
|
α-HBDH | U/L |
|
Creatine Kinase, CK | U/L |
|
Creatine kinase isoenzyme, CKMB | U/L |
|
Date of tests | yyyy-mm-dd |
|
|
|
Signature of the doctor |
|
yyyy-mm-dd |
|
|
|
ALT | IU/L |
|
AST | IU/L |
|
AST/ALT |
|
|
γ-Glutamyltransferase | IU/L |
|
GGT | U/L |
|
Serum bilirubin | μmol/L |
|
Indirect bilirubin | umol/L |
|
Direct bilirubin | umol/L |
|
Serum albumin | g/L |
|
Serum globulin | g/L |
|
Serum total protein | g/L |
|
A/G |
|
|
Date of test | yyyy-mm-dd |
|
BUN | 8mmol/L |
|
SCr | μmol/L |
|
Blood urea | mmol/L |
|
Blood uric acid | μmol/L |
|
Cr |
|
|
Blood endogenous creatinine clearance | ml·s-1/m*2 |
|
BUN/Cr |
|
|
Date of test | yyyy-mm-dd |
|
|
|
|
|
|
|
|
ALT | IU/L |
|
AST | IU/L |
|
AST/ALT |
|
|
γ-Glutamyltransferase | IU/L |
|
Serum bilirubin | μmol/L |
|
Indirect bilirubin | umol/L |
|
Direct bilirubin | umol/L |
|
Serum albumin | g/L |
|
Serum globulin | g/L |
|
Serum total protein | g/L |
|
A/G |
|
|
Date of test | yyyy-mm-dd |
|
BUN | 8mmol/L |
|
SCr | μmol/L |
|
Blood urea | mmol/L |
|
Blood uric acid | μmol/L |
|
Cr |
|
|
Date of test | yyyy-mm-dd |
- Management for Progress
- Blood Routine Tests
- Glucose test
- Liver Function Tests
- Renel Function Test
- Heat Function Examination
- Image Examinations
- Health Relative Quality of Life
|
Is there any additional combination drug? | |
次 |
|
WBC | ×109 /L |
|
NEUT% | % |
|
LY% | % |
|
MONO％ | ％ |
|
RBC | ×10^12 /L |
|
HGB | g/L |
|
PLT | ×10^9 /L |
|
Researcher signature |
|
|
Date | yyyy-mm-dd |
|
HbA1c | % |
|
Date of test | yyyy-mm-dd |
|
Blood glucose | mmol/L |
|
LAGE |
|
|
MAGE |
|
|
SDBG |
|
|
MODD |
|
|
LBGI |
|
|
Date of test | yyyy-mm-dd |
|
Daily usage of insulin | IU |
|
Date of detection | yyyy-mm-dd |
|
ALT | IU/L |
|
AST | IU/L |
|
AST/ALT |
|
|
γ-Glutamyltransferase | IU/L |
|
Serum bilirubin | μmol/L |
|
Indirect bilirubin | umol/L |
|
Direct bilirubin | umol/L |
|
Serum albumin | g/L |
|
Serum globulin | g/L |
|
Serum total protein | g/L |
|
A/G |
|
|
Date of test | yyyy-mm-dd |
|
BUN | 8mmol/L |
|
SCr | μmol/L |
|
Blood urea | mmol/L |
|
Blood uric acid | μmol/L |
|
Cr |
|
|
Date of test | yyyy-mm-dd |
|
Ultrasonic echocardiography, UCG | |
|
Description in detail for abnormal |
|
|
Date of examination | yyyy-mm-dd |
|
AST | U |
|
LDH | IU |
|
Lactic dehydrogenase isoenzyme | |
|
α-HBDH | U/L |
|
Creatine Kinase, CK | U/L |
|
Creatine kinase isoenzyme, CKMB | U/L |
|
Date of tests | yyyy-mm-dd |
|
Before primary wounding | 分 |
|
Now (Current at moment) | 分 |
|
|
|
Signature of the doctor |
|
|
Date of examination | yyyy-mm-dd |
|
Whether got the informed consent? | |
|
Date of sign the informed consent | xx年xx月xx日 |
|
Adverse events | |
|
Name of the adverse event |
|
|
Date of starting | yyyy-mm-dd |
|
Ending time | yyyy-mm-dd |
|
Does it continues to now | |
|
Severity | |
|
Corelation with the study drug | |
|
The method of treating the drug | |
|
The outcome | |
|
Is it sevious adverse event? | |
|
Did it resulted in stoped the study? | |
|
Possible reason of causing the adverse event | |
|
Person who report the adverse event |
|
|
Time of the reporting | yyyy-mm-dd-hh-min. |